

![]()


IVD Contract Manufacturing Service Market Scope:

Request Sample Report

The IVD Contract Manufacturing Service market is experiencing robust growth, driven by rising demand for diagnostic solutions and innovations in personalized medicine. The market size is projected to reach approximately $12 billion by 2027, with key players enhancing capabilities to meet regulatory requirements and increasing outsourcing trends among diagnostic manufacturers.

Request Sample Report

◍ Cenogenics Corporation
◍ In-Vitro Diagnostic Developers Inc
◍ Savyon Diagnostics
◍ Elbit Systems Ltd. (KMC Systems, Inc.)
◍ Nova Biomedical
◍ LRE Medical
◍ Cone Bioproducts
◍ Invetech, Inc. (Subsidiary of Fortive Corporation)
◍ Avioq, Inc
◍ TCS Biosciences Ltd
◍ Affinity Life Sciences, Inc
◍ Coris BioConcept
◍ Meridian Bioscience, Inc.
◍ Affinity Biologicals Inc.
◍ Biokit S.A.
◍ Merck KGaA
◍ Maxim Biomedical, Inc
The IVD contract manufacturing service market features companies like Cenogenics, In-Vitro Diagnostic Developers, and Meridian Bioscience, which leverage their expertise to develop, manufacture, and innovate diagnostic products. Their capabilities enhance market growth through improved efficiency and quality. Notable sales revenues include:

- Meridian Bioscience: $174 million
- Merck KGaA: $24 billion (overall sales).
Request Sample Report


Reagents and Consumables
Instruments and Systems
Others
Request Sample Report
Manufacturing Services
Assay Development Services
Others



Request Sample Report
$ X Billion USD












